Connor, Clark & Lunn Investment Management (CC&L)’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-74,573
Closed -$5.48M 1536
2023
Q4
$5.48M Buy
74,573
+20,835
+39% +$1.33M 0.03% 397
2023
Q3
$3.35M Buy
+53,738
New +$3.61M 0.02% 490
2022
Q1
Sell
-77,926
Closed -$6.54M 1042
2021
Q4
$6.54M Sell
77,926
-11,840
-13% -$949K 0.03% 296
2021
Q3
$7.01M Buy
89,766
+77,588
+637% +$6.45M 0.04% 292
2021
Q2
$925K Buy
+12,178
New +$850K ﹤0.01% 680
2020
Q1
Sell
-5,500
Closed -$280K 1024
2019
Q4
$280K Buy
+5,500
New +$262K ﹤0.01% 774
2018
Q3
Sell
-51,400
Closed -$1.49M 933
2018
Q2
$1.49M Sell
51,400
-2,425
-5% -$73.7K 0.01% 532
2018
Q1
$1.61M Buy
+53,825
New +$1.75M 0.01% 416
2017
Q4
Sell
-10,550
Closed -$314K 781
2017
Q3
$314K Buy
+10,550
New +$304K ﹤0.01% 701

Other funds holding BRKR

Connor, Clark & Lunn Investment Management (CC&L)'s BRKR Position: Q1 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Bruker (BRKR) in Q1 2024, closing a stake of 74,573 shares — an estimated $5.48M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BRKR in Q3 2017 and held it in 9 quarters. The position peaked at $7.01M in Q3 2021. 389 funds tracked by Wall St. Rank hold BRKR as of Q1 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Bruker position as of Q1 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 74,573 Bruker shares in Q1 2024, an estimated $5.48M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Bruker in Q3 2017 and held it in 9 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Bruker position peaked at $7.01M in Q3 2021.
  • 389 funds tracked by Wall St. Rank held Bruker as of Q1 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2024, filed 9 May 2024.